4
Changes in Ownership
Axogen, Inc. Filed Acc 0001179110-18-012900
VP, Clinical&Translational Sc acquired 35,274 shares (option exercise)
- VP, Clinical&Translational Sc gave up 2,882 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2018-11-13 | Option exercise | +35,000 | $2.74 | $95,900 | 40,018 | D |
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2018-11-13 | Shares withheld for taxes | −2,882 | $33.28 | $95,913 | 37,136 | D |
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2018-11-13 | Option exercise | +274 | $0.27 | $74 | 37,410 | D |
| Derivatives | |||||||
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2018-11-13 | Option exercise · Employee Stock Option (right to purchase) | −35,000 | 0 | D | ||
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2018-11-13 | Option exercise · Employee Stock Option (right to purchase) | −274 | 0 | D | ||
Loading xslF345X03/edgar.xml…